Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Naja Emborg Vinding"'
Autor:
Lukas Schak, Jeppe Kofoed Petersen, Naja Emborg Vinding, Charlotte Andersson, Peter E. Weeke, Søren Lund Kristensen, Anna Gundlund, Morten Schou, Lars Køber, Emil Loldrup Fosbøl, Lauge Østergaard
Publikováno v:
International Journal of Cardiology. 382:23-32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::176677b442b51dfdfebe0d188840ad61
https://doi.org/10.1016/j.ijcard.2023.04.007
https://doi.org/10.1016/j.ijcard.2023.04.007
Autor:
Sam Aiyad Ali, Mads Ersbøll, Naja Emborg Vinding, Jawad Haider Butt, Rasmus Rørth, Christian Selmer, Lucas Malta Westergaard, Ulrik Madvig Mogensen, Peter E Weeke, Christian Jøns, Finn Gustafsson, Emil Fosbøl, Lars Køber, Søren Lund Kristensen
Publikováno v:
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
AimsThyroid dysfunction is considered the most frequent complication to amiodarone treatment, but data on its occurrence outside clinical trials are sparse. The present study aimed to examine the incidence of thyroid dysfunction following initiation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::145656368b1797d032663a1c495e08c9
https://pubmed.ncbi.nlm.nih.gov/36504263
https://pubmed.ncbi.nlm.nih.gov/36504263
Autor:
Johanna Krøll, Camilla H.B. Jespersen, Søren Lund Kristensen, Emil L. Fosbøl, Naja Emborg Vinding, Freddy Lippert, Kristian Kragholm, Christian Jøns, Steen M. Hansen, Lars Køber, Peter Karl Jacobsen, Jacob Tfelt-Hansen, Peter E. Weeke
Publikováno v:
Krøll, J, H. B. Jespersen, C, Lund Kristensen, S, Fosbøl, E L, Emborg Vinding, N, Lippert, F, Kragholm, K, Jøns, C, Hansen, S M, Køber, L, Karl Jacobsen, P, Tfelt-Hansen, J & Weeke, P E 2022, ' Use of torsades de pointes risk drugs among patients with out-of-hospital cardiac arrest and likelihood of shockable rhythm and return of spontaneous circulation : a nationwide study ', Resuscitation, vol. 179, pp. 105-113 . https://doi.org/10.1016/j.resuscitation.2022.08.008
Aim: Treatment with certain drugs can augment the risk of developing malignant arrhythmias (e.g. torsades de pointes [TdP]). Hence, we examined the overall TdP risk drug use before out-of-hospital cardiac arrest (OHCA) and possible association with s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::933465dc22e3b885846a537f968f5431
https://pubmed.ncbi.nlm.nih.gov/35964772
https://pubmed.ncbi.nlm.nih.gov/35964772
Autor:
Lars Køber, Emil L. Fosbøl, Christina Kruuse, Christian Torp-Pedersen, Adelina Yafasova, Jeppe Kofoed Petersen, Rikke Sørensen, Lauge Østergaard, Naja Emborg Vinding, Anna Gundlund, Jawad H. Butt
Publikováno v:
Petersen, J K, Butt, J H, Yafasova, A, Torp-Pedersen, C, Sørensen, R, Kruuse, C, Vinding, N E, Gundlund, A, Køber, L, Fosbøl, E L & Østergaard, L 2021, ' Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation : a nationwide study ', European Heart Journal, vol. 42, no. 44, ehab575, pp. 4553-4561 . https://doi.org/10.1093/eurheartj/ehab575
Aims The aim of this study was to examine contemporary data on the 1-year prognosis of patients surviving acute coronary syndrome (ACS) and concomitant first-time detected atrial fibrillation (AF). Methods and results Using Danish nationwide registri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a5ee750797e7ae286cf542a8a2a96df
https://vbn.aau.dk/da/publications/7b3c87c1-865c-4fe6-9ac3-f911e13a5686
https://vbn.aau.dk/da/publications/7b3c87c1-865c-4fe6-9ac3-f911e13a5686
Autor:
Adelina Yafasova, Helle K. Iversen, Rasmus Rørth, Christina Kruuse, Naja Emborg Vinding, Christine Benn Christiansen, Christian Torp-Pedersen, Kristian Kragholm, Emil L. Fosbøl, Hanne Christensen, Gunnar Gislason, Søren Paaske Johnsen, Lars Køber, Jawad H. Butt
Publikováno v:
Butt, J H, Kragholm, K, Kruuse, C, Christensen, H, Iversen, H K, Johnsen, S P, Rørth, R, Vinding, N E, Yafasova, A, Christiansen, C B, Gislason, G H, Torp-Pedersen, C, Køber, L & Fosbøl, E L 2021, ' Workforce Attachment after Ischemic Stroke – The Importance of Time to Thrombolytic Therapy ', Journal of Stroke and Cerebrovascular Diseases, vol. 30, no. 11, 106031 . https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106031
Objectives: The ability to remain in employment addresses an important consequence of stroke beyond the usual clinical parameters. However, data on the association between time to intravenous thrombolysis and workforce attachment in patients with acu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c03c5b20b1210918128727ab9c70aba3
https://vbn.aau.dk/ws/files/449068260/Butt_et_al._2021_._Workforce_Attachment_after_Ischemic_Stroke_The_Importance_of_Time_to_Thrombolytic_Therapy.pdf
https://vbn.aau.dk/ws/files/449068260/Butt_et_al._2021_._Workforce_Attachment_after_Ischemic_Stroke_The_Importance_of_Time_to_Thrombolytic_Therapy.pdf
Autor:
Jonas Bjerring Olesen, Christian Torp-Pedersen, Christina Ji-Young Lee, Lars Køber, Naja Emborg Vinding, Gunnar Gislason, Rasmus Rørth, Emil L. Fosbøl, Anders Nissen Bonde, Laila Staerk
Publikováno v:
Vinding, N E, Staerk, L, Gislason, G H, Torp-Pedersen, C, Bonde, A N, Rørth, R, Lee, C J-Y, Olesen, J B, Køber, L & Fosbøl, E L 2021, ' Switching from Vitamin K Antagonist to Dabigatran in Atrial Fibrillation : Differences According to Dose ', European heart journal. Cardiovascular pharmacotherapy, vol. 7, no. 1, pp. 20–30 . https://doi.org/10.1093/ehjcvp/pvz066
European Heart Journal — Cardiovascular Pharmacotherapy
Vinding, N E, Staerk, L, Gislason, G H, Torp-Pedersen, C, Bonde, A N, Rørth, R, Lee, C J-Y, Olesen, J B, Køber, L & Fosbøl, E L 2021, ' Switching from Vitamin K Antagonist to Dabigatran in Atrial Fibrillation : Differences According to Dose ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 7, no. 1, pp. 20-30 . https://doi.org/10.1093/ehjcvp/pvz066
European Heart Journal — Cardiovascular Pharmacotherapy
Vinding, N E, Staerk, L, Gislason, G H, Torp-Pedersen, C, Bonde, A N, Rørth, R, Lee, C J-Y, Olesen, J B, Køber, L & Fosbøl, E L 2021, ' Switching from Vitamin K Antagonist to Dabigatran in Atrial Fibrillation : Differences According to Dose ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 7, no. 1, pp. 20-30 . https://doi.org/10.1093/ehjcvp/pvz066
Aims In atrial fibrillation (AF) patients 150 mg b.i.d. dabigatran is the standard dose, yet guidelines recommend 110 mg b.i.d. when bleeding risk is high. It is unknown to which extend these recommendations are followed in patients switching from vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abb6b90a515decd95c2c85526e13c7ae
https://doi.org/10.1093/ehjcvp/pvz066
https://doi.org/10.1093/ehjcvp/pvz066
Autor:
Adelina Yafasova, Gunnar Gislason, Jeppe Kofoed Petersen, Christina Kruuse, Jawad H. Butt, Lars Køber, Søren Paaske Johnsen, Amna Alhakak, Emil L. Fosbøl, Christian Torp-Pedersen, Naja Emborg Vinding
Publikováno v:
Yafasova, A, Fosbøl, E L, Johnsen, S P, Kruuse, C, Petersen, J K, Alhakak, A, Vinding, N E, Torp-Pedersen, C, Gislason, G H, Køber, L & Butt, J H 2021, ' Time to Thrombolysis and Long-Term Outcomes in Patients With Acute Ischemic Stroke : A Nationwide Study ', Stroke, vol. 52, no. 5, pp. 1724-1732 . https://doi.org/10.1161/STROKEAHA.120.032837
Yafasova, A, Fosbøl, E L, Johnsen, S P, Kruuse, C, Petersen, J K, Alhakak, A, Vinding, N E, Torp-Pedersen, C, Gislason, G H, Køber, L & Butt, J H 2021, ' Time to Thrombolysis and Long-Term Outcomes in Patients with Acute Ischemic Stroke : A Nationwide Study ', Stroke, vol. 52, no. 5, pp. 1724-1732 . https://doi.org/10.1161/STROKEAHA.120.032837
Yafasova, A, Fosbøl, E L, Johnsen, S P, Kruuse, C, Petersen, J K, Alhakak, A, Vinding, N E, Torp-Pedersen, C, Gislason, G H, Køber, L & Butt, J H 2021, ' Time to Thrombolysis and Long-Term Outcomes in Patients with Acute Ischemic Stroke : A Nationwide Study ', Stroke, vol. 52, no. 5, pp. 1724-1732 . https://doi.org/10.1161/STROKEAHA.120.032837
Background and Purpose: It is well-established that increasing treatment delay reduces the benefits of thrombolysis in patients with acute ischemic stroke. However, most studies focus on short-term outcomes. This study examined long-term outcomes acc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe33278ff7b4fad3eba854ea7dfa9cbf
https://vbn.aau.dk/da/publications/47bf0b06-70e1-44db-8907-191841daa65a
https://vbn.aau.dk/da/publications/47bf0b06-70e1-44db-8907-191841daa65a
Autor:
Jawad H. Butt, Charlotte Andersson, Mia N. Christiansen, Adelina Yafasova, Christina Kruuse, Lars Koeber, Torp-Pedersen Ct, Gunnar Gislason, E L Fosboel, Søren Paaske Johnsen, Naja Emborg Vinding
Publikováno v:
European Heart Journal. 41
Background The incidence and mortality of ischaemic heart disease have been declining over many years. The development with ischaemic stroke is less well studied, and with an increasing elderly population, there is a need for large-scale studies. Rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5baa00cb67385cb163c26223daacaf4
https://doi.org/10.1093/ehjci/ehaa946.2411
https://doi.org/10.1093/ehjci/ehaa946.2411
Autor:
Adelina Yafasova, Torp-Pedersen Ct, E L Fosboel, Jeppe Kofoed Petersen, Jawad H. Butt, Søren Paaske Johnsen, Gunnar Gislason, Naja Emborg Vinding, Lars Koeber, Amna Alhakak, Christina Kruuse
Publikováno v:
European Heart Journal. 41
Background It is well-established that the short-term benefits of intravenous thrombolytic therapy are reduced with increasing treatment delay in patients with acute ischaemic stroke. However, there is a paucity of contemporary data on the associatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3e3619d32a48f5600fcaf37b08fd8ab
https://doi.org/10.1093/ehjci/ehaa946.2416
https://doi.org/10.1093/ehjci/ehaa946.2416
Autor:
Emil L. Fosbøl, Christina Kruuse, Naja Emborg Vinding, Lars Køber, Adelina Yafasova, Christian Torp-Pedersen, Charlotte Andersson, Mia N. Christiansen, Jawad H. Butt, Gunnar Gislason, Søren Paaske Johnsen
Publikováno v:
Yafasova, A, Fosbøl, E L, Christiansen, M N, Vinding, N E, Andersson, C, Kruuse, C, Johnsen, S P, Gislason, G H, Torp-Pedersen, C, Køber, L & Butt, J H 2020, ' Time trends in incidence, comorbidity, and mortality of ischemic stroke in Denmark, 1996-2016 ', Neurology, vol. 95, no. 17, pp. e2343-e2353 . https://doi.org/10.1212/WNL.0000000000010647
Yafasova, A, Fosbøl, E L, Christiansen, M N, Vinding, N E, Andersson, C, Kruuse, C, Johnsen, S P, Gislason, G H, Torp-Pedersen, C, Køber, L & Butt, J H 2020, ' Time trends in incidence, comorbidity, and mortality of ischemic stroke in Denmark (1996-2016) ', Neurology, vol. 95, no. 17, pp. e2343-e2353 . https://doi.org/10.1212/WNL.0000000000010647
Yafasova, A, Fosbøl, E L, Christiansen, M N, Vinding, N E, Andersson, C, Kruuse, C, Johnsen, S P, Gislason, G H, Torp-Pedersen, C, Køber, L & Butt, J H 2020, ' Time trends in incidence, comorbidity, and mortality of ischemic stroke in Denmark (1996-2016) ', Neurology, vol. 95, no. 17, pp. e2343-e2353 . https://doi.org/10.1212/WNL.0000000000010647
ObjectiveTo examine whether the incidence, comorbidity, and mortality of first-time ischemic stroke changed in Denmark between 1996 and 2016 overall and according to age and sex using a nationwide cohort design.MethodsIn this cohort study, 224,617 in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08658dec025c51cd2505b232f8d01e39
https://vbn.aau.dk/da/publications/4983c9ab-2bf9-4297-98c1-33c869f47933
https://vbn.aau.dk/da/publications/4983c9ab-2bf9-4297-98c1-33c869f47933